Definitive Contract 75F40119C10015
Award Date 3/28/19
Potential Completion Date 3/23/24
Potential Value $790K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Laurel, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the procurement of the MiSeq whole genome sequencing instrument, a genome sequencer, with a ceiling value of $166,207.78 and a period of performance through June 30, 2029. The contract is not set aside for any specific business designation. Illumina holds multiple federal...
- This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $21,183, is for the provision of preventative maintenance services for Illumina's MiSeq benchtop sequencer. The contract does not have a set-aside designation. Illumina has extensive experience providing sequencing systems, reagents, and maintenance services to a variety of...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $87,870.00 contract is for the provision of a MiSeq DNA sequencing system and related consumables. The award has no set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease...
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a diagnostic check and system upgrades for the MiSeq Whole Genome Sequencer at six FDA laboratories. The $84,733.20 contract has a completion date of December 31, 2022 and was sole-sourced to Illumina due to the proprietary nature of the MiSeq technology. Illumina has previously provided sequencing systems,...
- This firm fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The $576,928.00 contract is for the procurement of an Illumina NextSeq2000 Sequencing System, including associated reagents and maintenance services. The contract has a period of performance through July 20, 2026. Illumina is a key technology provider for federal scientific and diagnostic...
- This firm fixed-price delivery order, valued at $201,939.00, was awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The award does not have a set-aside designation. Illumina is a manufacturer of genetic sequencing systems and has a history of supporting genomic research and diagnostics across multiple federal agencies. This award indicates Illumina is providing maintenance services to help ensure the...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The $184,226.00 contract has an ultimate completion date of December 5, 2016. Illumina is a for-profit manufacturer and provider of genomic sequencing and analysis solutions. Through prior federal contracts, Illumina has supplied a range of sequencing systems, reagents, and related services to...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for $170,153.16 to provide annual on-site preventative maintenance service and unlimited repairs as needed on two Illumina MiSeq whole genome sequencers for a base year plus four option years. The contract has no set-aside designation. Based on Illumina's history as a prime contractor and subcontractor for sequencing systems and services across various federal agencies, this award aligns...
- This $81,810 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq instrument and does not have a set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention...